Ізраїль - англійська - Ministry of Health

neopharm (israel) 1996 ltd - meropenem as anhydrous - powder for solution for inj/inf - meropenem as anhydrous 1000 mg/vial - meropenem - for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Ізраїль - англійська - Ministry of Health

neopharm (israel) 1996 ltd - meropenem as anhydrous - powder for solution for inj/inf - meropenem as anhydrous 500 mg/vial - meropenem - for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Ізраїль - англійська - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Ізраїль - англійська - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 500 mg/vial - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - meropenem trihydrate 1.14155 g equivalent to of meroopenem 1 g;   - powder for injection - 1 g - active: meropenem trihydrate 1.14155 g equivalent to of meroopenem 1 g   excipient: nitrogen sodium carbonate - indicated for treatment, in adults and children, of lower respiratory tract infections.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - meropenem trihydrate 570.78mg equivalent to meropenem 500 mg;   - powder for injection - 500 mg - active: meropenem trihydrate 570.78mg equivalent to meropenem 500 mg   excipient: nitrogen sodium carbonate - indicated for treatment, in adults and children, of lower respiratory tract infections.

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - meropenem - powder for solution for injection/infusion - 0.5 gram(s) - carbapenems; meropenem

Кенія - англійська - Pharmacy and Poisons Board

kopran limited 1076,parijat house, dr. e.moses road, worli, - meropenem for injection usp - powder for solution for injection/infusion - meropenem 1000 mg (as meropenem trihydrate) - meropenem

Сінгапур - англійська - HSA (Health Sciences Authority)

sumitomo pharma asia pacific pte. ltd. - meropenem trihydrate 1140mg eqv anhydrous meropenem - injection, powder, for solution - 1000 mg - meropenem trihydrate 1140mg eqv anhydrous meropenem 1 g/vial

Мальта - англійська - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - meropenem - powder for solution for infusion or injection - meropenem 500 mg - antibacterials for systemic use